Skip to main content
TipRanks
Go Ultimate75% OFF

Santhera Pharmaceuticals Holding (SANN) Q2 2019 Earnings Report

6 Followers

CH:SANN Q2 2019 EPS Results

Actual EPS
-CHF 24.70
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-CHF 42.50

CH:SANN Q2 2019 Revenue Results

Actual Revenue
CHF 18.32M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+14.28%

Earnings Announcement Details

Quarter
Q2 2019
Date
09/03/2019
Time
Before Open
Conference Call
Tuesday, September 3, 2019
CH:SANN Upcoming Earnings

Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.

Q2 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:SANN Earnings History

CH:SANN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 29, 20272026 (Q4)―--0.43――
Sep 30, 20262026 (Q2)0.17-1.50-0.37-305.41% (-1.13)
Apr 28, 20262025 (Q4)-0.43-0.43-0.7441.89% (+0.31)
Sep 23, 20252025 (Q2)-0.60-3.04-1.35-125.19% (-1.69)
Apr 29, 20252024 (Q4)-0.74-0.747.27-110.18% (-8.01)
Sep 12, 20242024 (Q2)-0.94-1.35-1.5814.56% (+0.23)
Apr 25, 20242023 (Q4)―7.27-2.13441.31% (+9.40)
Sep 07, 20232023 (Q2)-1.58-1.58-5.2469.85% (+3.66)
Apr 27, 20232022 (Q4)―-2.13-2.37.39% (+0.17)
Oct 31, 20222022 (Q2)―-5.24-9.2243.19% (+3.98)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed